Bristol-Myers Squibb Company (BMY)
Receivables turnover
| Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 48,194,000 | 48,300,000 | 45,006,000 | 46,159,000 | 46,385,000 |
| Receivables | US$ in thousands | 9,592,000 | 14,424,000 | 15,264,000 | 13,937,000 | 12,516,000 |
| Receivables turnover | 5.02 | 3.35 | 2.95 | 3.31 | 3.71 |
December 31, 2025 calculation
Receivables turnover = Revenue ÷ Receivables
= $48,194,000K ÷ $9,592,000K
= 5.02
Peer comparison
Dec 31, 2025
Company name
Symbol
Receivables turnover
Bristol-Myers Squibb Company
BMY
5.02
AbbVie Inc
ABBV
—
Amgen Inc
AMGN
3.84
Biogen Inc
BIIB
7.31
Eli Lilly and Company
LLY
3.23
Gilead Sciences Inc
GILD
—
Johnson & Johnson
JNJ
5.48
Merck & Company Inc
MRK
—
Organon & Co
OGN
—
Pfizer Inc
PFE
—